- Home
- QLGN vs PTPI Comparison
QLGN vs PTPI Comparison
Compare QLGN & PTPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QLGN
- PTPI
- Stock Information
- Founded
- QLGN 1996
- PTPI 2020
- Country
- QLGN United States
- PTPI United States
- Employees
- QLGN N/A
- PTPI N/A
- Industry
- QLGN Biotechnology: Pharmaceutical Preparations
- PTPI Biotechnology: Pharmaceutical Preparations
- Sector
- QLGN Health Care
- PTPI Health Care
- Exchange
- QLGN Nasdaq
- PTPI Nasdaq
- Market Cap
- QLGN 3.4M
- PTPI 3.6M
- IPO Year
- QLGN N/A
- PTPI N/A
- Fundamental
- Price
- QLGN $4.18
- PTPI $0.36
- Analyst Decision
- QLGN
- PTPI
- Analyst Count
- QLGN 0
- PTPI 0
- Target Price
- QLGN N/A
- PTPI N/A
- AVG Volume (30 Days)
- QLGN 54.9K
- PTPI 1.7M
- Earning Date
- QLGN 11-14-2024
- PTPI 11-13-2024
- Dividend Yield
- QLGN N/A
- PTPI N/A
- EPS Growth
- QLGN N/A
- PTPI N/A
- EPS
- QLGN N/A
- PTPI N/A
- Revenue
- QLGN N/A
- PTPI $4,022,389.00
- Revenue This Year
- QLGN N/A
- PTPI N/A
- Revenue Next Year
- QLGN N/A
- PTPI $0.76
- P/E Ratio
- QLGN N/A
- PTPI N/A
- Revenue Growth
- QLGN N/A
- PTPI N/A
- 52 Week Low
- QLGN $3.34
- PTPI $0.22
- 52 Week High
- QLGN $30.50
- PTPI $2.27
- Technical
- Relative Strength Index (RSI)
- QLGN 43.01
- PTPI 48.85
- Support Level
- QLGN $3.53
- PTPI $0.26
- Resistance Level
- QLGN $4.39
- PTPI $0.59
- Average True Range (ATR)
- QLGN 0.33
- PTPI 0.06
- MACD
- QLGN 0.06
- PTPI 0.01
- Stochastic Oscillator
- QLGN 50.98
- PTPI 16.38
About QLGN Qualigen Therapeutics Inc.
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.
About PTPI Petros Pharmaceuticals Inc.
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.